Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Patent
1994-03-31
1997-06-17
Chan, Christina Y.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
5303882, 53038885, 5303891, 5303911, 5303913, 5303917, 435332, C12N 512, C07K 1628, A61K 5110
Patent
active
056396562
ABSTRACT:
The invention provides compositions and methods for use in detecting benign prostate hyperplasia (BPH) and for differentiating BPH from normal prostate tissues and prostate cancer. Disclosed are monoclonal antibodies (MAbs) directed against a highly restricted biological marker of BPH, hybridoma cells secreting such MAbs and various methods for making and using BPH-specific antigens and antibodies, including methods and kits for the detection of BPH antigens and the diagnosis and therapy of BPH.
REFERENCES:
patent: Re33405 (1990-10-01), Chu et al.
patent: 4446122 (1984-05-01), Chu et al.
patent: 4863851 (1989-09-01), McEwan et al.
patent: 5153118 (1992-10-01), Wright, Jr. et al.
patent: 5227471 (1993-07-01), Wright, Jr.
Muraro et al., Cancer Research, 1988, 48:4588.
Basta et al., "Cytokeratin Shedding in Urine: a Biological Marker for Bladder Cancer?," British Journal of Urology, 61:116-121, 1988.
Bostwick et al., "Prostatic Intra-Epithelial Neoplasia and Early Invasion in Prostate Cancer," Cancer, 59:788-794, 1987.
Brawer et al., "Keratin Immunoreactivity in the Benign and Neoplastic Human Prostate," Cancer Research, 45:3663-3667, 1985.
Edwards et al., "Proteins of Human Urine. II. Identification by Two-Dimensional Electrophoresis of a New Candidate Marker for Prostatic Cancer," Clin. Chem., 28(1):160-163, 1982.
Merz et al., "Differential Expression of mRNAs Transporting Growth Factor .beta.1 and .beta.3 and C-POS in Human Normal Prostate, Benign Prostatic Hyperplasia and Prostatic Cancer,"J. Urology, 149 (4), Supplement, p. 472A, Abstract #1038, 1993.
Pagano et al., "Is There a Relationship between Benign Prostatic Hyperplasia and Prostatic Cancer?," Eur. Urol., 20(suppl 2):31-35, 1991.
Partin et al., "Nuclear Matrix Protein Patterns in Human Benign Prostatic Hyperplasia and Prostate Cancer," Cancer Research, 53:744-746, 1993.
Starling et al., "Human Prostate Tissue Antigens Defined by Murine Monoclonal Antibodies," Cancer Research, 46:367-374, 1986.
Theyer et al., "Phenotypic Characterization of Infiltrating Leukocytes in Benign Prostatic Hyperplasia," Laboratory Investigation, 66(1):96-107, 1992.
Tsai et al., "Systematic Characterization of Human Prostatic Fluid Proteins with Two-Dimensional Electrophoresis," Clin. Chem., 30(12):2026-2030, 1984.
Verhagen et al., "Colocalization of Basal and Luminal Cell-type Cytokeratins in Human Prostate Cancer," Cancer Research, 52:6182-6187, 1992.
Wright, Jr. et al., "Prostate Tumor-Specific Mucin-Like Antigen Differentiates Benign Prostate Hyperplasia From Well-Differentiated Prostate Adenocarcinoma," J. Urology, 145(4) Supplement, p. 295A, Abstract #329, 1991.
Wright, Jr. et al., "Differentiation of Benign Prostate Hyperplasia From Prostate Adenocarcinoma with Monoclonal Antibodies," Proceedings of AACR, 28, p. 349, Abstract #1384, 1987.
Wright, Jr. et al., "BP52: A Biomarker of Benign Prostate Hyperplasia," J. Urology, 151:297a, Abstract #279, 1994.
J.W. Goding, Monoclonal Antibodies: Principles and Practice, 1986, pp. 12, 78-85, 124-134, 282-287.
Wright et al., Int. J. Canc., 1991, 47:717.
Aguila et al., Immunotechnica, 1988, 2(2):1.
Chan Christina Y.
Eisenschenk Frank C.
Medical College of Hampton Road
LandOfFree
Antibodies reactive with biological markers of benign prostate h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies reactive with biological markers of benign prostate h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies reactive with biological markers of benign prostate h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157249